Neurocrine Biosciences Inc (NBIX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: NBIX Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-05-16 2024-05-15 PS Planned sale

ABERNETHY MATT

Chief Financial Officer

Officer
1,000 -32.2%
140.24
100,000 USD 		1,000 -32.2% 140.24 100,000 USD
2024-05-16 2024-05-14 PS Planned sale

ABERNETHY MATT

Chief Financial Officer

Officer
1,000 -32.2%
135.66
100,000 USD 		1,000 -32.2% 135.66 100,000 USD
2024-05-08 2024-05-06 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
1,000 -3.5%
140.55
100,000 USD 		1,000 -3.5% 140.55 100,000 USD
2024-04-17 2024-04-15 PS Planned sale

BENEVICH ERIC

Chief Commercial Officer

Officer
12,587 -23.6%
133.36
1,678,660 USD 		12,587 -23.6% 133.36 1,678,660 USD
2024-04-17 2024-04-15 PS Planned sale

BENEVICH ERIC

Chief Commercial Officer

Officer
7,231 -15.1%
133.36
964,359 USD 		7,231 -15.1% 133.36 964,359 USD
2024-04-03 2024-04-01 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
272 -3.5%
137.30
37,346 USD 		272 -3.5% 137.30 37,346 USD
2024-03-25 2024-03-21 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
5,000 -40.0%
145.06
725,320 USD 		5,000 -40.0% 145.06 725,320 USD
2024-03-15 2024-03-14 PS Planned sale

BENEVICH ERIC

Chief Commercial Officer

Officer
69,521 -63.0%
139.38
9,689,761 USD 		69,521 -63.0% 139.38 9,689,761 USD
2024-03-15 2024-03-14 PS Planned sale

BENEVICH ERIC

Chief Commercial Officer

Officer
5,479 -11.8%
139.38
763,657 USD 		5,479 -11.8% 139.38 763,657 USD
2024-03-15 2024-03-14 PS Planned sale

MORROW GEORGE J

Non-Executive Director
20,000 -100.0%
139.41
2,788,278 USD 		20,000 -100.0% 139.41 2,788,278 USD
2024-03-15 2024-03-14 PS Planned sale

MORROW GEORGE J

Non-Executive Director
20,000 -100.0%
139.42
2,788,432 USD 		20,000 -100.0% 139.42 2,788,432 USD
2024-03-15 2024-03-13 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
3,000 -28.6%
140.14
420,419 USD 		3,000 -28.6% 140.14 420,419 USD
2024-03-15 2024-03-13 PS Planned sale

POPS RICHARD F

Non-Executive Director
23,200 -44.0%
140.33
3,255,621 USD 		23,200 -44.0% 140.33 3,255,621 USD
2024-03-12 2024-03-11 PS Planned sale

POPS RICHARD F

Non-Executive Director
100 -0.3%
140.00
14,000 USD 		100 -0.3% 140.00 14,000 USD
2024-03-12 2024-03-11 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
200 -2.6%
140.00
28,000 USD 		200 -2.6% 140.00 28,000 USD
2024-03-12 2024-03-08 PS Planned sale

POPS RICHARD F

Non-Executive Director
1,700 -5.4%
140.05
238,078 USD 		1,700 -5.4% 140.05 238,078 USD
2024-03-12 2024-03-08 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
1,800 -19.3%
140.03
252,053 USD 		1,800 -19.3% 140.03 252,053 USD
2024-02-29 2024-02-29 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
273 -3.5%
135.51
36,994 USD 		273 -3.5% 135.51 36,994 USD
2024-02-29 2024-02-28 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
1,544 -17.1%
136.00
209,984 USD 		1,544 -17.1% 136.00 209,984 USD
2024-02-29 2024-02-28 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
2,500 -25.0%
134.62
336,550 USD 		2,500 -25.0% 134.62 336,550 USD
2024-02-29 2024-02-28 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
2,500 -25.0%
135.64
339,104 USD 		2,500 -25.0% 135.64 339,104 USD
2024-02-29 2024-02-28 PS Planned sale

BENEVICH ERIC

Chief Commercial Officer

Officer
21,857 -35.0%
134.69
2,943,878 USD 		21,857 -35.0% 134.69 2,943,878 USD
2024-02-29 2024-02-28 PS Planned sale

BENEVICH ERIC

Chief Commercial Officer

Officer
53,143 -56.7%
134.69
7,157,730 USD 		53,143 -56.7% 134.69 7,157,730 USD
2024-02-29 2024-02-27 PS Planned sale

Norwalk Leslie V

Non-Executive Director
8,000 -100.0%
135.67
1,085,388 USD 		8,000 -100.0% 135.67 1,085,388 USD
2024-02-22 2024-02-20 PS Planned sale

POPS RICHARD F

Non-Executive Director
15,000 -33.7%
132.47
1,987,047 USD 		15,000 -33.7% 132.47 1,987,047 USD
2024-02-15 2024-02-13 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
716 -8.7%
133.03
95,253 USD 		716 -8.7% 133.03 95,253 USD
2024-02-15 2024-02-13 PS Planned sale

ROBERTS EIRY

Chief Medical Officer

Officer
1,114 -4.5%
132.96
148,122 USD 		1,114 -4.5% 132.96 148,122 USD
2024-02-15 2024-02-13 PS Planned sale

Boyer David W.

Chief Corp. Affairs Officer

Officer
856 -14.9%
133.05
113,889 USD 		856 -14.9% 133.05 113,889 USD
2024-02-15 2024-02-13 PS Planned sale

Boyer David W.

Chief Corp. Affairs Officer

Officer
955 -14.2%
133.10
127,106 USD 		955 -14.2% 133.10 127,106 USD
2024-02-15 2024-02-13 PS Planned sale

ABERNETHY MATT

Chief Financial Officer

Officer
1,352 -4.1%
132.85
179,612 USD 		1,352 -4.1% 132.85 179,612 USD
2024-02-15 2024-02-13 PS Planned sale

Cooke Julie

Chief Human Resources Officer

Officer
796 -4.2%
133.04
105,902 USD 		796 -4.2% 133.04 105,902 USD
2024-02-15 2024-02-13 PS Planned sale

Gano Kyle

Chief Business Development Off

Officer
1,352 -1.0%
132.89
179,674 USD 		1,352 -1.0% 132.89 179,674 USD
2024-02-15 2024-02-13 PS Planned sale

Lippoldt Darin

Chief Legal Officer

Officer
1,098 -2.7%
132.99
146,028 USD 		1,098 -2.7% 132.99 146,028 USD
2024-02-15 2024-02-13 PS Planned sale

BENEVICH ERIC

Chief Commercial Officer

Officer
1,098 -2.6%
133.01
146,050 USD 		1,098 -2.6% 133.01 146,050 USD
2024-02-15 2024-02-13 PS Planned sale

Onyia Jude

Chief Scientific Officer

Officer
1,432 -9.8%
132.94
190,371 USD 		1,432 -9.8% 132.94 190,371 USD
2024-02-15 2024-02-13 PS Planned sale

GORMAN KEVIN CHARLES

Chief Executive Officer

Executive Director
2,832 -0.5%
133.02
376,700 USD 		2,832 -0.5% 133.02 376,700 USD
2024-02-08 2024-02-08 PS Planned sale

Lippoldt Darin

Chief Legal Officer

Officer
911 -2.3%
134.24
122,289 USD 		911 -2.3% 134.24 122,289 USD
2024-02-08 2024-02-08 PS Planned sale

Gano Kyle

Chief Business Development Off

Officer
980 -0.7%
134.20
131,519 USD 		980 -0.7% 134.20 131,519 USD
2024-02-08 2024-02-08 PS Planned sale

ABERNETHY MATT

Chief Financial Officer

Officer
980 -3.1%
134.21
131,529 USD 		980 -3.1% 134.21 131,529 USD
2024-02-08 2024-02-08 PS Planned sale

BENEVICH ERIC

Chief Commercial Officer

Officer
980 -2.4%
134.19
131,509 USD 		980 -2.4% 134.19 131,509 USD
2024-02-08 2024-02-08 PS Planned sale

ROBERTS EIRY

Chief Medical Officer

Officer
980 -4.1%
134.21
131,522 USD 		980 -4.1% 134.21 131,522 USD
2024-02-08 2024-02-08 PS Planned sale

Boyer David W.

Chief Corp. Affairs Officer

Officer
628 -11.4%
136.78
85,898 USD 		628 -11.4% 136.78 85,898 USD
2024-02-08 2024-02-08 PS Planned sale

Boyer David W.

Chief Corp. Affairs Officer

Officer
700 -11.2%
134.19
93,932 USD 		700 -11.2% 134.19 93,932 USD
2024-02-08 2024-02-08 PS Planned sale

GORMAN KEVIN CHARLES

Chief Executive Officer

Executive Director
2,274 -0.4%
134.15
305,052 USD 		2,274 -0.4% 134.15 305,052 USD
2024-02-08 2024-02-08 PS Planned sale

Cooke Julie

Chief Human Resources Officer

Officer
629 -3.5%
136.78
86,035 USD 		629 -3.5% 136.78 86,035 USD
2024-02-08 2024-02-08 PS Planned sale

Cooke Julie

Chief Human Resources Officer

Officer
700 -3.8%
134.23
93,961 USD 		700 -3.8% 134.23 93,961 USD
2024-02-08 2024-02-06 PS Planned sale

Lippoldt Darin

Chief Legal Officer

Officer
1,041 -2.7%
142.17
147,995 USD 		1,041 -2.7% 142.17 147,995 USD
2024-02-08 2024-02-06 PS Planned sale

Gano Kyle

Chief Business Development Off

Officer
1,600 -1.2%
142.20
227,522 USD 		1,600 -1.2% 142.20 227,522 USD
2024-02-08 2024-02-06 PS Planned sale

ABERNETHY MATT

Chief Financial Officer

Officer
1,280 -4.2%
142.19
182,000 USD 		1,280 -4.2% 142.19 182,000 USD
2024-02-08 2024-02-06 PS Planned sale

BENEVICH ERIC

Chief Commercial Officer

Officer
1,280 -3.2%
142.12
181,910 USD 		1,280 -3.2% 142.12 181,910 USD
2024-02-08 2024-02-06 PS Planned sale

ROBERTS EIRY

Chief Medical Officer

Officer
1,121 -4.9%
142.24
159,446 USD 		1,121 -4.9% 142.24 159,446 USD
2024-02-08 2024-02-06 PS Planned sale

Boyer David W.

Chief Corp. Affairs Officer

Officer
216 -4.2%
141.96
30,663 USD 		216 -4.2% 141.96 30,663 USD
2024-02-08 2024-02-06 PS Planned sale

Boyer David W.

Chief Corp. Affairs Officer

Officer
240 -4.5%
141.96
34,070 USD 		240 -4.5% 141.96 34,070 USD
2024-02-08 2024-02-06 PS Planned sale

GORMAN KEVIN CHARLES

Chief Executive Officer

Executive Director
3,040 -0.6%
142.18
432,218 USD 		3,040 -0.6% 142.18 432,218 USD
2024-02-08 2024-02-06 PS Planned sale

Cooke Julie

Chief Human Resources Officer

Officer
575 -3.2%
141.96
81,627 USD 		575 -3.2% 141.96 81,627 USD
2024-02-08 2024-02-06 PS Planned sale

Cooke Julie

Chief Human Resources Officer

Officer
640 -3.5%
142.17
90,990 USD 		640 -3.5% 142.17 90,990 USD
2024-02-02 2024-02-01 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
623 -8.3%
139.77
87,077 USD 		623 -8.3% 139.77 87,077 USD
2024-02-02 2024-01-31 PS Planned sale

BENEVICH ERIC

Chief Commercial Officer

Officer
1,207 -3.1%
140.78
169,927 USD 		1,207 -3.1% 140.78 169,927 USD
2024-02-02 2024-01-31 PS Planned sale

ABERNETHY MATT

Chief Financial Officer

Officer
1,283 -4.3%
140.72
180,539 USD 		1,283 -4.3% 140.72 180,539 USD
2024-02-02 2024-01-31 PS Planned sale

Onyia Jude

Chief Scientific Officer

Officer
126 -1.1%
141.94
17,884 USD 		126 -1.1% 141.94 17,884 USD
2024-02-02 2024-01-31 PS Planned sale

Boyer David W.

Chief Corp. Affairs Officer

Officer
992 -16.9%
140.72
139,591 USD 		992 -16.9% 140.72 139,591 USD
2024-02-02 2024-01-31 PS Planned sale

Boyer David W.

Chief Corp. Affairs Officer

Officer
1,104 -15.8%
140.87
155,524 USD 		1,104 -15.8% 140.87 155,524 USD
2024-02-02 2024-01-31 PS Planned sale

GORMAN KEVIN CHARLES

Chief Executive Officer

Executive Director
2,707 -0.5%
140.69
380,845 USD 		2,707 -0.5% 140.69 380,845 USD
2024-02-02 2024-01-31 PS Planned sale

Lippoldt Darin

Chief Legal Officer

Officer
1,250 -3.3%
140.65
175,810 USD 		1,250 -3.3% 140.65 175,810 USD
2024-02-02 2024-01-31 PS Planned sale

Gano Kyle

Chief Business Development Off

Officer
1,541 -1.2%
140.70
216,813 USD 		1,541 -1.2% 140.70 216,813 USD
2024-02-02 2024-01-31 PS Planned sale

Cooke Julie

Chief Human Resources Officer

Officer
824 -4.6%
141.94
116,959 USD 		824 -4.6% 141.94 116,959 USD
2024-02-02 2024-01-31 PS Planned sale

Cooke Julie

Chief Human Resources Officer

Officer
916 -4.8%
140.70
128,883 USD 		916 -4.8% 140.70 128,883 USD
2024-02-02 2024-01-31 PS Planned sale

Delaet Ingrid

Chief Regulatory Officer

Officer
422 -6.3%
141.94
59,899 USD 		422 -6.3% 141.94 59,899 USD
2024-02-02 2024-01-31 PS Planned sale

ROBERTS EIRY

Chief Medical Officer

Officer
1,457 -6.5%
140.79
205,132 USD 		1,457 -6.5% 140.79 205,132 USD
2024-01-24 2024-01-22 PS Planned sale

Lippoldt Darin

Chief Legal Officer

Officer
10,000 -21.8%
139.86
1,398,553 USD 		10,000 -21.8% 139.86 1,398,553 USD
2024-01-10 2024-01-09 PS Planned sale

GORMAN KEVIN CHARLES

Chief Executive Officer

Executive Director
62,023 -11.0%
134.01
8,311,895 USD 		62,023 -11.0% 134.01 8,311,895 USD
2024-01-10 2024-01-08 PS Planned sale

GORMAN KEVIN CHARLES

Chief Executive Officer

Executive Director
105,835 -17.5%
132.44
14,016,523 USD 		105,835 -17.5% 132.44 14,016,523 USD
2024-01-04 2024-01-02 PS Planned sale

Gano Kyle

Chief Business Development Off

Officer
6,116 -4.5%
131.44
803,905 USD 		6,116 -4.5% 131.44 803,905 USD
2024-01-04 2024-01-02 PS Planned sale

Gano Kyle

Chief Business Development Off

Officer
68,884 -34.6%
131.47
9,056,290 USD 		68,884 -34.6% 131.47 9,056,290 USD
2024-01-04 2024-01-02 PS Planned sale

RASTETTER WILLIAM H

Non-Executive Director
11,044 -17.6%
131.47
1,451,927 USD 		11,044 -17.6% 131.47 1,451,927 USD